| Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676) |
|---|
| 03/14/2007 | EP1517895B1 8-(biaryl) quinoline pde4 inhibitors |
| 03/14/2007 | CN1930128A Quinoline intermediates of receptor tyrosine kinase inhibitors and the synthesis thereof |
| 03/14/2007 | CN1930127A Process for the synthesis of cxcr4 antagonist |
| 03/14/2007 | CN1930105A Method for preparation of a fluoroaromatic compound from an aminoaromatic amine compound |
| 03/14/2007 | CN1929840A 8-hydroxy-5- [(-hydroxy-2- [[ (1R)-2-(4-methoxyphenyl)-1-methylethyl] amino ][ethyl -2(1H)-quinolinone monohydrochloride in crystalline form and the process for its preparation |
| 03/14/2007 | CN1304390C Novel gamma secretase inhibitors |
| 03/14/2007 | CN1304374C Quinoline derivatives as caspase-3 inhibitor, preparation for producing the same and pharmaceutical composition |
| 03/14/2007 | CN1304373C Method for preparing aripiprazole and its intermediate |
| 03/14/2007 | CN1304365C Acylated arylcycloalkylamines and their use as pharmaceuticals |
| 03/14/2007 | CN1304108C Method for isomerizing allyl alcohols |
| 03/13/2007 | US7189864 Forming a diastereoselective epoxide from a chiral alpha-amino aldehyde; efficient synthesis of intermediates which are readily amenable to the large scale preparation of hydroxyethylurea-based chiral HIV protease inhibitors |
| 03/13/2007 | US7189853 Process for the preparation of [R-(E)-1-[[[1-[3-[2-[7-chloro-2-quinolinyl]ethenyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]thio]methyl]cyclopropaneacetic acid (Montelukast) and its pharmaceutically acceptable salts |
| 03/13/2007 | US7189722 Aryl spirohydantoin CGRP receptor antagonists |
| 03/13/2007 | US7189715 Compositions comprising zopiclone derivatives and methods of making and using the same |
| 03/13/2007 | US7189714 Administering quinoline derivative as analgesic |
| 03/13/2007 | CA2295106C 3-anilino-2-cycloalkenone derivatives |
| 03/08/2007 | WO2007027599A1 9-aminocarbonylsubstituted derivatives of glycylcyclines |
| 03/08/2007 | WO2007025709A2 Organic compounds |
| 03/08/2007 | WO2007005668A3 Bis-aryl kinase inhibitors and their use in the treatment of inflammation, angiogenesis and cancer |
| 03/08/2007 | WO2005112933A3 Substituted organosulfur compounds and methods of using thereof |
| 03/08/2007 | WO2005086844A3 Magnetism to control friction checks for rods |
| 03/08/2007 | US20070054938 Quinoline derivative, e.g. 2[4-(7-chloroquinolin-2-yloxy)phenoxy]propionic acid sodium salt; anticarcinogenic, antitumor agent; colon, breast, melanoma, pancreatic cancer or adenocarcinoma; melanoma, or leukemia; based on herbicides |
| 03/08/2007 | US20070054936 such as 4-(5-formyl-2-methoxy-phenyl)-7-trifluoromethyl-quinoline-3-carboxylic acid ethyl ester; urinary incontinence, overactive bladder, hypertension, erectile dysfunction, benign prostate hyperplasia, female sexual disorders, premature labor, dysmenorrhea, irritable bowl syndrome, airway hyperactivity |
| 03/08/2007 | US20070054928 c-Met modulators and methods of use |
| 03/08/2007 | US20070054923 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 03/08/2007 | US20070054922 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 03/08/2007 | US20070054921 Substituted indoles and a process for preparing substituted indoles |
| 03/08/2007 | US20070054920 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 03/08/2007 | US20070054904 Phenol derivatives and their use as rotamase inhibitors |
| 03/08/2007 | US20070054898 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 03/08/2007 | US20070051929 Rare metal compounds and mixtures of these |
| 03/08/2007 | CA2620600A1 9-aminocarbonylsubstituted derivatives of glycylcyclines |
| 03/08/2007 | CA2620222A1 Organic compounds |
| 03/08/2007 | CA2616473A1 4-aryloxy quinoline derivatives as 5-ht6 modulators |
| 03/07/2007 | EP1760077A1 Montelukast free acid polymorphs |
| 03/07/2007 | EP1758884A2 N-cyclic sulfonamido inhibitors of gamma secretase |
| 03/07/2007 | EP1758865A1 Pyridine analogs as c5a antagonists |
| 03/07/2007 | EP1758863A1 Tetrahydroquinolones and aza-analogues thereof for use as dpp-iv inhibitors in the treatement of diabetes |
| 03/07/2007 | CN1926097A Derivatives of heteroaryl-alkylcarbamates, preparation method thereof and use of same as FAAH enzyme inhibitors |
| 03/07/2007 | CN1923816A Method for producing condensed imidazole compound, reformatsky reagent having stable form and production thereof |
| 03/07/2007 | CN1923781A Method of synthesizing compound containing difluoromethyl group |
| 03/07/2007 | CN1303074C Heteroaryl alkyl piperazine derivatives as fatty acid oxidation inhibitors |
| 03/07/2007 | CN1303068C Preparation of Alipioxazole |
| 03/06/2007 | US7186840 Quinoline derivatives as anti-inflammatory agents |
| 03/06/2007 | US7186839 Extraction uisng aqueous solution containing metal compound |
| 03/06/2007 | US7186735 Vasodilation; cardiovascular disorders; anticoagulants |
| 03/06/2007 | US7186732 For therapy and prophylaxis of upper airway allergic response, nasal congestion, or allergic rhinitis, dementia, mild cognitive impairment (pre-dementia), cognitive dysfunction, schizophrenia, depression, manic disorders |
| 03/06/2007 | US7186724 central nervous system disorders; psychological disorders; Parkinson's disease; Huntington's disease ; sleep disorders |
| 03/06/2007 | CA2129159C Substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them |
| 03/01/2007 | WO2007023290A1 Tetrahydroquinolinones and their use as modulators of metabotropic glutamate receptors |
| 03/01/2007 | WO2007023242A1 Tetrahydroquinolinones and their use as modulators of metabotropic glutamate receptors |
| 03/01/2007 | WO2007022964A2 Hetaryl-substituted guanidine compounds and use thereof as binding partners for 5-ht5-receptors |
| 03/01/2007 | WO2007022946A1 Heterocyclic compounds and their use as binding partners for 5-ht5 receptors |
| 03/01/2007 | WO2006119713A3 Antineoplastic compounds and pharmaceutical compositions thereof |
| 03/01/2007 | WO2006081273A8 3-aryl-3-hydroxy-2-amino-propionic acid amides, 3-heteroayryl-3-hydroxy-2-amino-propionic acid amides and related compounds having analgesic and/or immunostimulant activity |
| 03/01/2007 | US20070049570 Quinoline derivatives as phosphodiesterase inhibitors |
| 02/28/2007 | EP1757584A1 Heterocyclic substituted amides, their production and their use |
| 02/28/2007 | EP1756062A1 Compounds and compositions as ppar modulators |
| 02/28/2007 | EP1756044A1 Therapeutic compounds |
| 02/28/2007 | EP1756029A1 Novel compounds, the preparation and the use thereof for a regiospesific synthesis of perfluor(alkyl) group heterocycles |
| 02/28/2007 | EP1492771B1 Quinoline and isoquinoline derivatives, method for the production thereof and use thereof as anti-inflammatory agents |
| 02/28/2007 | EP1415987B1 Nitrogenous aromatic ring compounds as anti cancer agents |
| 02/28/2007 | EP1379505B1 Inhibition of raf kinase using quinolyl, isoquinolyl or pyridyl ureas |
| 02/28/2007 | EP1240154B1 Serine protease inhibitors |
| 02/28/2007 | CN1922162A Derivatives of alkylpiperazine- and alkylhomopiperazine-carboxylates, preparation method thereof and use of same as FAAH enzyme inhibitors |
| 02/28/2007 | CN1922161A Derivatives of 1-piperazine- and 1-homopiperazine-carboxylates, preparation method thereof and use of same in therapeutics |
| 02/28/2007 | CN1922146A Tetrahydroquinolones and their use as modulators of metabotropic glutamate receptors |
| 02/28/2007 | CN1922145A Improved process for preparing rebamipide |
| 02/28/2007 | CN1922138A Aryloxyalkylcarbamate-type derivatives, preparation method thereof and use of same in therapeutics |
| 02/28/2007 | CN1922135A 免疫抑制剂化合物和组合物 Immunosuppressant compounds and compositions |
| 02/28/2007 | CN1919525A Quinolinols as fluxing and accelerating agents for underfill compositions |
| 02/27/2007 | US7183415 Melanin-concentrating hormone antagonistic action for treating obesity, for example 4'-fluoro-N-[8-methyl-3-(1-pyrrolidinylmethyl)-7-quinolinyl][1,1'-biphenyl]-4-carboxamide |
| 02/27/2007 | US7183414 Processes for the preparation of benzoimidazole derivatives |
| 02/27/2007 | US7183413 Aminoquinoline compounds |
| 02/27/2007 | US7183412 Ester or amide derivatives |
| 02/27/2007 | US7183411 Naphthol, quinoline and isoquinoline-derived urea modulators of vanilloid VR1 receptor |
| 02/27/2007 | US7183374 Diminishing concentration of metal complex from solution containing the complex by addition of an optionally fused and/or optionally substituted heterocyclic compound which is a solubility-enhancing compound that enhances solubility of complex in second solution |
| 02/27/2007 | US7183320 For therapy of neoplastic diseases |
| 02/27/2007 | US7183291 Method for the treatment of malaria by the use of primaquine derivative N1-(3-ethylidinotetrahydrofuran-2-one)-N4- (6-methoxy-8-quinolinyl)-1,4-pentanediamine as gametocytocidal agent |
| 02/27/2007 | US7183273 Administering compounds such as N-(2-pyridinylmethyl)-N'-(6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridin-9-yl)-1,4-benzenedimethanamine for therapy of disease mediated by a chemokine receptor |
| 02/22/2007 | WO2007021464A1 Hindered cyclic polyamines and their salts for acid gas scrubbing process |
| 02/22/2007 | WO2006065842A3 5,6,7,8-tetrahydroquinolines and related compounds and uses thereof |
| 02/22/2007 | WO2006059103A3 Pyridine based compounds useful as intermediates for pharmaceutical or agricultural end-products |
| 02/22/2007 | WO2005123077A8 Heteroaryl sulfones and sulfonamides and therapeutic uses thereof |
| 02/22/2007 | US20070043042 Quinoline potassium channel inhibitors |
| 02/22/2007 | US20070043007 Specific glucocorticosteroid compounds having anti-inflammatory activity |
| 02/22/2007 | US20070042996 N-alkynyl-2-(substituted aryloxy) alkylthioamine derivatives as fungicides |
| 02/22/2007 | DE69530936C5 Boronsäure-und-esterverbindungen, deren systhese und verwendungen Boronic acid and ester compounds whose systhese and uses |
| 02/22/2007 | CA2750864A1 Bis-aryl amide compounds and methods of use |
| 02/22/2007 | CA2619706A1 Novel high affinity quinoline-based kinase ligands |
| 02/21/2007 | EP1753724A1 Heterocyclic derivatives for treatment of hyperlipidemia and related diseases |
| 02/21/2007 | EP1753723A1 Substituted quinoline derivatives as mitotic kinesin inhibitors |
| 02/21/2007 | EP1753421A2 Arylsulfonamides and uses as hydroxysteroid dehydrogenase |
| 02/21/2007 | EP1551798B1 Novel sulphones for inhibition of gamma secretase |
| 02/21/2007 | EP1311482B1 Non-imidazole aryloxypiperidines as h3 receptor ligands |
| 02/21/2007 | EP1255749B1 Tyrosine derivatives with anti-leukotriene activity |
| 02/21/2007 | EP1133474B1 3-substituted-4-arylquinolin-2-one derivatives as potassium channel modulators |
| 02/21/2007 | CN1918145A Amino heterocyclic modulators of chemokine receptor activity |
| 02/21/2007 | CN1918118A Thioamide compound or its salt and cytokine production inhibitor containing the same |
| 02/21/2007 | CN1917873A Diurea derivatives |